Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low-level viraemia.

Zhong-Bin LiLe LiXiao-Xia NiuSong-Hai ChenYi-Ming FuChun-Yan WangYan LiuQing ShaoGuofeng ChenDong Ji

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

For ETV-treated patients with LLV, switching to TAF is safe enough and superior compared with continuing ETV monotherapy regarding both virological and biochemical benefits.

Keyphrases

acute lymphoblastic leukemia
antiretroviral therapy
hepatitis b virus
hiv infected
combination therapy
hiv infected patients
medical education
newly diagnosed